Artificial intelligence for diabetes care: current and future prospects
Document Type
Article
Publication Date
8-1-2024
Abstract
Artificial intelligence (AI) use in diabetes care is increasingly being explored to personalise care for people with diabetes and adapt treatments for complex presentations. However, the rapid advancement of AI also introduces challenges such as potential biases, ethical considerations, and implementation challenges in ensuring that its deployment is equitable. Ensuring inclusive and ethical developments of AI technology can empower both healthcare providers and people with diabetes in managing the condition. In this Review, we explore and summarise the current and future prospects of AI across the diabetes care continuum, from enhancing screening and diagnosis to optimising treatment and predicting and managing complications.
Divisions
medicinedept
Funders
Shanghai Key Discipline of Public Health (GWVI11.120),General Fund of the National Natural Science Foundation of China (62272298),National Key Research & Development Program of China (2022YFA1004804),National Natural Science Foundation of China (NSFC) (82022012),Innovative research team of highlevel local universities in Shanghai (SHSMUZDCX20212700),National University Health System, Singapore (2023)
Publication Title
Lancet Diabetes & Endocrinology
Volume
12
Issue
8
Publisher
Elsevier
Publisher Location
STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA